Eliglustat
Back to searchMolecule Structure
Scientific Name
Eliglustat
Description of the Drug
Eliglustat is a glucosylceramide synthase used to treat type 1 Gaucher disease in patients who are CYP2D6 extensive, intermediate, or poor metabolizers.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB09039
http://www.drugbank.ca/drugs/DB09039
Brand Name(s)
Cerdelga
Company Owner(s)
Teva Pharmaceuticals Usa Inc, Dr Reddys Laboratories Ltd, Aizant Drug Research Solutions Pvt Ltd, Genzyme Corp
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Ceramide glucosyltransferase | SINGLE PROTEIN | INHIBITOR | CHEMBL2063 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL421755 | ||
| PharmGKB | PA166123486 | ||
| DrugBank | DB09039 | ||
| PubChem: Thomson Pharma | 46524644 | ||
| PubChem | 23652731 | ||
| Nikkaji | J3.029.957D | ||
| DrugCentral | 4834 | ||
| Brenda | 209215 | ||
| ChemicalBook | CB52627796 | ||
| Guide to Pharmacology | 7536 | ||
| rxnorm | CERDELGA | ELIGLUSTAT | ELIGLUSTAT TARTRATE |
| ChEBI | 82752 | ||
| ZINC | ZINC000072267023 |
